Juvaris BioTherapeutics raises $25 million
Juvaris BioTherapeutics Inc., a Pleasanton, Calif.-based developer of vaccines for cancer and infectious diseases, has raised $25 million in the first close of a Series B round.
Cytheris SA, a French drug startup focused on immune modulation, has raised €12 million in Series D funding.